Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1985 1
1994 3
1995 3
1996 3
1997 5
1998 4
1999 8
2000 5
2001 8
2002 10
2003 8
2004 9
2005 9
2006 4
2007 4
2008 10
2009 9
2010 6
2011 7
2012 8
2013 8
2014 13
2015 11
2016 8
2017 14
2018 16
2019 8
2020 6
2021 8
2022 8
2023 12
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Results by year

Filters applied: . Clear all
Page 1
Taxane anticancer agents: a patent perspective.
Ojima I, Lichtenthal B, Lee S, Wang C, Wang X. Ojima I, et al. Expert Opin Ther Pat. 2016;26(1):1-20. doi: 10.1517/13543776.2016.1111872. Epub 2015 Dec 10. Expert Opin Ther Pat. 2016. PMID: 26651178 Free PMC article. Review.
Great Challenges in Organic Chemistry.
Ojima I. Ojima I. Front Chem. 2017 Jul 12;5:52. doi: 10.3389/fchem.2017.00052. eCollection 2017. Front Chem. 2017. PMID: 28748181 Free PMC article. No abstract available.
FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer.
M Swamynathan M, Mathew G, Aziz A, Gordon C, Hillowe A, Wang H, Jhaveri A, Kendall J, Cox H, Giarrizzo M, Azabdaftari G, Rizzo RC, Diermeier SD, Ojima I, Bialkowska AB, Kaczocha M, Trotman LC. M Swamynathan M, et al. Among authors: ojima i. Cancers (Basel). 2023 Dec 21;16(1):60. doi: 10.3390/cancers16010060. Cancers (Basel). 2023. PMID: 38201488 Free PMC article.
The Future of Antifungal Drug Therapy: Novel Compounds and Targets.
Mota Fernandes C, Dasilva D, Haranahalli K, McCarthy JB, Mallamo J, Ojima I, Del Poeta M. Mota Fernandes C, et al. Among authors: ojima i. Antimicrob Agents Chemother. 2021 Jan 20;65(2):e01719-20. doi: 10.1128/AAC.01719-20. Print 2021 Jan 20. Antimicrob Agents Chemother. 2021. PMID: 33229427 Free PMC article. Review.
Drug resistance mechanisms and novel drug targets for tuberculosis therapy.
Islam MM, Hameed HMA, Mugweru J, Chhotaray C, Wang C, Tan Y, Liu J, Li X, Tan S, Ojima I, Yew WW, Nuermberger E, Lamichhane G, Zhang T. Islam MM, et al. Among authors: ojima i. J Genet Genomics. 2017 Jan 20;44(1):21-37. doi: 10.1016/j.jgg.2016.10.002. Epub 2016 Oct 11. J Genet Genomics. 2017. PMID: 28117224 Review.
Overcoming multidrug resistance in taxane chemotherapy.
Geney R, Ungureanu lM, Li D, Ojima I. Geney R, et al. Among authors: ojima i. Clin Chem Lab Med. 2002 Sep;40(9):918-25. doi: 10.1515/CCLM.2002.161. Clin Chem Lab Med. 2002. PMID: 12435109 Review.
224 results